SI-BONE Announces Pricing of Public Offering of Common Stock
23 January 2020 - 12:30PM
SI-BONE, Inc. (Nasdaq: SIBN) (“SI-BONE”), a Silicon Valley-based
medical device company dedicated to solving musculoskeletal
disorders of the sacropelvic anatomy, today announced the pricing
of its public offering of 4,300,000 shares of its common stock at a
price to the public of $21.50 per share. Of the shares of
common stock being offered, 1,809,947 shares are being offered by
selling stockholders and 2,490,053 shares are being offered by
SI-BONE. Gross proceeds to SI-BONE from the offering are
expected to be $53.5 million, before deducting underwriting
discounts and commissions and estimated offering expenses.
The offering is scheduled to close on January 27, 2020, subject to
the satisfaction of customary closing conditions. In
addition, SI-BONE has granted the underwriters a 30-day option to
purchase up to an additional 645,000 shares of common stock on the
same terms and conditions.
Morgan Stanley and BofA Securities are acting as
joint book-running managers. Canaccord Genuity LLC and JMP
Securities LLC are acting as co-managers.
A shelf registration statement relating to the
shares being sold in this offering was filed with the U.S.
Securities and Exchange Commission on December 26, 2019, and was
declared effective on January 2, 2020. A preliminary prospectus
supplement and accompanying prospectus relating to the offering was
filed with the SEC and are available for free on the SEC’s
website located at http://www.sec.gov. When available,
electronic copies of the final prospectus supplement and
accompanying prospectus relating to the offering are may be
obtained from Morgan Stanley & Co. LLC, Attention: Prospectus
Department, 180 Varick Street, 2nd Floor, New York, New York 10014;
or from BofA Securities, NC1-004-03-43, 200 North College Street,
3rd floor, Charlotte NC 28255-0001, Attn: Prospectus
Department, or email at dg.prospectus_requests@bofa.com.
This press release shall not constitute an offer
to sell or the solicitation of an offer to buy, nor shall there be
any sale of these securities in any state or jurisdiction in which
such offer, solicitation, or sale would be unlawful prior to
registration or qualification under the securities laws of any such
state or jurisdiction.
About SI-BONE
SI-BONE is a medical device company that
pioneered minimally invasive surgery of the SI joint with the iFuse
Implant System.
SI-BONE and iFuse Implant System are registered
trademarks of SI-BONE, Inc. iFuse Implant is a trademark of
SI-BONE, Inc. ©2020 SI-BONE, Inc. All Rights Reserved.
10608.01222020
Forward-Looking Statements
This press release contains forward-looking statements,
including statements relating to SI-BONE’s expectations regarding
the underwritten public offering. These statements are subject to
significant risks and uncertainties and actual results could differ
materially from those projected. SI-BONE cautions investors not to
place undue reliance on the forward-looking statements contained in
this release. These risks and uncertainties include, without
limitation, completion of the underwritten public offering is
subject to the satisfaction of customary closing conditions. Risks
and uncertainties relating to SI-BONE and its business can be found
in the “Risk Factors” section of SI-BONE’s Form 10-Q for the
quarter ended September 30, 2019, filed with the SEC on November
12, 2019, in the preliminary prospectus supplement related to the
public offering filed with the SEC on January 21, 2020, and
in the final prospectus supplement related to the public
offering to be filed with the SEC on or about January 23, 2020.
SI-BONE undertakes no duty or obligation to update any
forward-looking statements contained in this release as a result of
new information, future events or changes in SI-BONE’s
expectations, except as required by law.
Investor Contact:Lynn Lewis or
Carrie Mendivilinvestors@SI-BONE.com
Media Contact:Joe
Powersjpowers@si-bone.com
SI BONE (NASDAQ:SIBN)
Historical Stock Chart
From Aug 2024 to Sep 2024
SI BONE (NASDAQ:SIBN)
Historical Stock Chart
From Sep 2023 to Sep 2024